It has been reported from our laboratories that expression of
CYP2E1 significantly increased and decreased in rats with
acute renal failure induced by
uranyl nitrate (U-ARF) treated with recombinant
human growth hormone (rGH) for one day (U-ARF1) compared with those in control rats and rats with U-ARF, respectively.
Chlorzoxazone (CZX) primarily undergoes hydroxylation to form
6-hydroxychlorzoxazone (
OH-CZX) catalyzed mainly by
CYP2E1 in rats. Hence, the effects of rGH on the pharmacokinetics of intravenous CZX (20 mg/kg) were investigated in rats with U-ARF. Based on
CYP2E1 expression, it could be expected that in rats with U-ARF1, the formation of
OH-CZX significantly increased and decreased compared with those in control rats and rats with U-ARF, respectively. This was proven in the following results. First, the total area under the plasma concentration-time curve from time zero to 8 hr (AUC(0-->8 hr)) of
OH-CZX in rats with U-ARF1 (36,100 microg min/ml) was significantly greater and smaller than those in control rats (1040 microg min/ml) and rats with U-ARF (50,300 microg min/ml), respectively. Second, the AUC(0-->8 hr,
OH-CZX)/AUC(CZX) ratio in rats with U-ARF1 (28.9) was significantly greater and smaller than those in control rats (0.468) and rats with U-ARF (72.6), respectively.